4/A//SEC Filing
NPS PHARMACEUTICALS INC 4/A
Accession 0001263259-03-000004
CIK 0000890465operating
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:02 PM ET
Size
5.8 KB
Accession
0001263259-03-000004
Insider Transaction Report
Form 4/AAmended
STILLER CALVIN
Director
Transactions
- Sale
Common Stock
2003-09-11$32.00/sh−24,000$768,000→ 195,043 total(indirect: Canadian Medical Discoveries Fund Inc.) - Sale
Common Stock
2003-09-09$32.00/sh−20,000$640,000→ 219,043 total(indirect: Canadian Medical Discoveries Fund Inc.)
Holdings
- 4,200
Common Stock
Footnotes (2)
- [F1]This transaction was executed under a Rule 10b5-1 trading plan.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of the person's pecuniary interest in the securities, if any.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000890465
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:02 PM ET
- Size
- 5.8 KB